Women’s healthcare company Hesta Health has opened early access to women in the first six months after birth for its postnatal health check programme, named Recovery.
Hesta Health Check Recovery is said to combine a number of features including a clinically designed online questionnaire, an at-home blood test measuring 51 different biomarkers across eight clinical domains, and a personalised guide to postnatal recovery. Results are reviewed by a postnatal clinician, offering insight into current health and areas which may require further attention, Hesta Health shares.
“Postnatal care should not require women and birthing parents to self-diagnose, self-refer and self-advocate at a time when they are already tired and busy,” the company writes on LinkedIn. “It should be joined up. Evidence-based. Compassionate.”
The company added the programme is delivered through their “CQC-registered service by the Hesta team of expert postnatal clinicians, and supported by a multidisciplinary team across pelvic health, mental health, gynaecology, nutrition, general practice and more.”
Currently, the early access option for the Health Check is £129 as an introductory offer.
Wider trend: Digital transformation in women’s health
The Scottish government has shared how the objectives set out in its Women’s Health Plan for Scotland are to be achieved across two phases. The first phase sets out priority areas to: ensure women have access to specialist menopause services for advice and support on the diagnosis and management of menopause; access to information for girls and women on menstrual health and management options; access for women to appropriate support, speedy diagnosis and best treatment for endometriosis; access to abortion and contraception services; rapid and easily accessible postnatal contraception; and to reduce inequalities in health outcomes for women’s general health, including work on cardiac disease.
Innovate UK has relaunched its Women in Innovation Awards for 2025–26, offering up to 60 awards a grant of up to £75,000, as part of a £4.5 million funding programme. Each successful application will receive a share of the funding, alongside business support, training, networking and role-modelling opportunities, Innovate UK noted. The programme is aimed at women founders and co-founders of late-stage startups, who are working on a minimum viable product, with early user interest or revenue, and has a growing team and plans to raise significant capital within the next 12 to 24 months.
US-based women’s telehealth company, Midi Health, has reportedly raised $100million in Series D funding, bringing its total valuation to $1billion. New investors include Foresite Capital and Serena Ventures, with Advance Venture Partners, Google Ventures, and Emerson Collective being among those who continued their support. Launched to tackle gaps in women’s healthcare, Midi has now expanded to become a scalable health platform offering insurance coverage to more than 45 million women, the company shares. With in excess of 25,000 patients looking for integrated care each week, it now relies on its proprietary AI engine to help with personalisation, streamlining of operations, and using health data to further research.
